发明授权
- 专利标题: Antibodies immunospecific for STEAP1
- 专利标题(中): 针对STEAP1免疫特异性的抗体
-
申请号: US10011095申请日: 2001-12-06
-
公开(公告)号: US07053186B2公开(公告)日: 2006-05-30
- 发明人: Daniel E. Afar , Rene S. Hubert , Kahan Leong , Arthur B. Raitano , Douglas C. Saffran , Stephen Chappell Mitchell
- 申请人: Daniel E. Afar , Rene S. Hubert , Kahan Leong , Arthur B. Raitano , Douglas C. Saffran , Stephen Chappell Mitchell
- 申请人地址: US CA Santa Monica
- 专利权人: Agensys, Inc.
- 当前专利权人: Agensys, Inc.
- 当前专利权人地址: US CA Santa Monica
- 代理机构: Shane M. Popp, LLM
- 代理商 Ginger R. Dreger, Esq.; Deirdre L. Conley
- 主分类号: C07K16/00
- IPC分类号: C07K16/00 ; C12P21/08
摘要:
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed “STRAP” (serpentine transmembrane antigens of the prostate). Four particular human STEAPs are described and characterized herein. The human STREPs exhibit a high degree of structural conservation among them but show no significant structural homology to any known human proteins. The prototype member of the STEAP family, STEAP-1, appears to be a type IIIa membrane protein expressed predominantly in prostate cells in normal human tissues. Structurally, STEAP-1 is a 339 amino acid protein characterized by a molecular topology of six transmembrane domains and intracellular N- and C-termini, suggesting that it folds in a “serpentine” manner into three extracellular and two intracellular loops. STREP-1 protein expression is maintained at high levels across various stages of prostate cancer. Moreover, STEAP-1 is highly over-expressed in certain other human cancers.
公开/授权文献
- US20030045682A1 Antibodies immunospecific for STEAP1 公开/授权日:2003-03-06
信息查询